Ligand Pharmaceuticals (LGND) Price to Sales (2011 - 2026)
Ligand Pharmaceuticals' (LGND) Price to Sales stood at 21.67 in Q2 2026, up 84.2% from 11.76 a year earlier and up 48.8% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Ligand Pharmaceuticals' Price to Sales came in at 13.95, up 13.9% from FY2024.
- Annual Price to Sales has increased for three straight years.
- Across earlier years, Price to Sales came in at 12.25 in FY2024 (+28.3%), 9.55 in FY2023 (+65.5%), 5.77 in FY2022 (-13.7%) and 6.69 in FY2021 (+9.7%).
- The Q2 2026 figure is the highest quarterly Price to Sales in data going back to Q1 2011.
- On a year-over-year basis, Price to Sales has increased for 14 consecutive quarters, with growth averaging 31.8% over the last eight quarters.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 84.2% in Q2 2026, against a decline of 35.5% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 14.57 (Q1 2026), 13.95 (Q4 2025) and 13.86 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Ligand Pharmaceuticals | 6.03 Bn | 2.50 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.67 |
| Mar 31, 2026 | 14.57 |
| Dec 31, 2025 | 13.95 |
| Sep 30, 2025 | 13.86 |
| Jun 30, 2025 | 11.76 |
| Mar 31, 2025 | 11.17 |
| Dec 31, 2024 | 12.25 |
| Sep 30, 2024 | 12.32 |
| Jun 30, 2024 | 11.43 |
| Mar 31, 2024 | 11.07 |
| Dec 31, 2023 | 9.55 |
| Sep 30, 2023 | 6.80 |
| Jun 30, 2023 | 6.95 |
| Mar 31, 2023 | 6.19 |
| Dec 31, 2022 | 5.77 |
| Sep 30, 2022 | 4.49 |
| Jun 30, 2022 | 4.63 |
| Mar 31, 2022 | 5.11 |
| Dec 31, 2021 | 6.69 |
| Sep 30, 2021 | 5.69 |
API Access
Ligand Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();